Hyperion Therapeutics - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Hyperion Therapeutics M&A Summary

Hyperion Therapeutics has acquired 1 company of its own.

Hyperion Therapeutics’ largest acquisition to date was in 2014, when it acquired Andromeda Biotech for $13M. The Company’s most targeted sectors include life science (100%).

Hyperion Therapeutics Ownership

Who owns Hyperion Therapeutics?

Hyperion Therapeutics is owned by Horizon Therapeutics Public Limited Company. It was acquired on April 3, 2015.

Was Hyperion Therapeutics formerly PE-backed?

Yes. Hyperion Therapeutics was formerly owned by 1 private investor.

Hyperion Therapeutics Business Overview

Where is Hyperion Therapeutics headquartered?

Hyperion Therapeutics is headquartered in Brisbane, California.

What sector is Hyperion Therapeutics in?

Hyperion Therapeutics is a life science company.

When was Hyperion Therapeutics founded?

Hyperion Therapeutics was founded in 2006.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Hyperion Therapeutics, Inc.

2000 Sierra Point Parkway, Suite 400,
Brisbane, California 94005
United States,
(650) 745-7802
www.hyperiontx.com

Hyperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 1 - - - - - 1
vol $13M $13M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Andromeda Biotech Ltd. 2014-06-12 13M USD Add-on Acquisition
Yavne, Israel
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 13M (100%) - -
Total 1 $13M - -

By Geo

State/Country Buy Value Sell Value
Israel 1 13M - -
Total 1 $13M - -

Deal Values

buy # Total
< $100M 1 $13M
TOTAL $13M
Largest Andromeda Biotech Ltd.
$13M (2014-06-12)

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Hyperion Therapeutics

Life Science Companies